Table 2:

Demographics and clinical features in subjectsa

SCISCNAQP4-Ab (+)AQP4-Ab (−)HCP1P2P3P4P5P6
No.171927920NANANANANANA
Age (yr)41.0 (20.5)41.0 (15.0)41.0 (12.0)41.0 (28.0)42.5 (7.5).297b.428b.827b.336b.390a.565b
Sex (M/F)3:144:152:255:47:13.383c.522c.797c.026c,d.422c.006c,d
Education (yr)9.0 (8.0)12.0 (3.0)12.0 (6.0)12.0 (3.5)9.0 (6.3).517b.095b.076b.570b.594b.667b
LSCL (VS)3.0 (5.0)0.0 (0.0)2.0 (5.0)0.0 (2.5)0.0 (0.0)NANANANANA.218b
AQP4-Ab (+/−)15/214/527/00/90/0NANA.271cNANANA
  • Note:—VS indicates vertebral segments; +, seropositive; −, seronegative; NA, not applicable.

  • a P1: comparison between the SCI and HC groups; P2: comparison between the SCN and HC groups; P3: comparison between the SCI and SCN groups; P4: comparison between the AQP4-Ab-seropositive and HC groups; P5: comparison between the AQP4-Ab-seronegative and HC groups; P6: comparison between the AQP4-Ab-seropositive and -seronegative groups. Variables are presented as median (interquartile range).

  • b The P value was obtained with the Mann-Whitney U test.

  • c The P value was obtained with the χ2 test.

  • d Significant.